Geode Capital Management’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-84,856
| Closed | -$3.37M | – | 4103 |
|
|
2016
Q3 | $3.37M | Buy |
84,856
+52,223
| +160% | +$583K | ﹤0.01% | 2217 |
|
|
2016
Q2 | $409K | Buy |
32,633
+410
| +1% | +$3.82K | ﹤0.01% | 3304 |
|
|
2016
Q1 | $263 | Buy |
32,223
+799
| +3% | +$6.03K | ﹤0.01% | 3533 |
|
|
2015
Q4 | $315K | Buy |
31,424
+5,588
| +22% | +$58K | ﹤0.01% | 3488 |
|
|
2015
Q3 | $249K | Buy |
+25,836
| New | +$363K | ﹤0.01% | 3582 |
|
|
2015
Q2 | – | Sell |
-12,196
| Closed | -$133K | – | 4006 |
|
|
2015
Q1 | $133K | Buy |
12,196
+25
| +0.2% | +$268 | ﹤0.01% | 3695 |
|
|
2014
Q4 | $100K | Buy |
12,171
+25
| +0.2% | +$215 | ﹤0.01% | 3789 |
|
|
2014
Q3 | $123K | Buy |
12,146
+17
| +0.1% | +$336 | ﹤0.01% | 3707 |
|
|
2014
Q2 | $741K | Buy |
12,129
+5,747
| +90% | +$350K | ﹤0.01% | 2980 |
|
|
2014
Q1 | $719K | Buy |
6,382
+4,691
| +277% | +$329K | ﹤0.01% | 2964 |
|
|
2013
Q4 | $72K | Hold |
1,691
| – | – | ﹤0.01% | 3650 |
|
|
2013
Q3 | $102K | Buy |
+1,691
| New | +$88.6K | ﹤0.01% | 3487 |
|
Geode Capital Management's TBRA Position: Q4 2016 in Review
Geode Capital Management sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 84,856 shares — an estimated $3.37M sold.
Geode Capital Management first reported a position in TBRA in Q3 2013 and held it in 12 quarters. The position peaked at $3.37M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.
- Geode Capital Management reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
- Geode Capital Management sold 84,856 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $3.37M.
- Geode Capital Management first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2013 and held it in 12 quarters.
- Geode Capital Management's Tobira Therapeutics, Inc. Common Stock position peaked at $3.37M in Q3 2016.
- 0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.
Based on Geode Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.